|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$53,023.68 |
2.75% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$51,850.88 |
2.69% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$50,818.35 |
2.64% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$49,726.14 |
2.58% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$49,435.70 |
2.56% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$48,536.48 |
2.52% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$46,344.42 |
2.40% |
| Waters Corporation |
WAT |
941848103 |
123 |
$46,357.47 |
2.40% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$45,308.60 |
2.35% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$44,109.48 |
2.29% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$42,426.28 |
2.20% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$42,151.10 |
2.19% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$42,058.89 |
2.18% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$41,174.62 |
2.14% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$40,980.55 |
2.13% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$40,798.08 |
2.12% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$40,840.76 |
2.12% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$40,131.60 |
2.08% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$40,132.03 |
2.08% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$39,886.17 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$39,994.47 |
2.07% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$39,954.25 |
2.07% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$39,656.30 |
2.06% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$38,993.28 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$38,601.90 |
2.00% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$38,385.12 |
1.99% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$38,103.61 |
1.98% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,770.60 |
1.96% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,611.74 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$37,302.60 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
177 |
$37,276.20 |
1.93% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$36,822.75 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$36,550.08 |
1.90% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$36,668.76 |
1.90% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$36,314.52 |
1.88% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,459.37 |
1.84% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,937.72 |
1.81% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$34,693.37 |
1.80% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$34,773.03 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$34,741.15 |
1.80% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$34,037.92 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$34,159.20 |
1.77% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$32,217.99 |
1.67% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$31,371.85 |
1.63% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$31,321.07 |
1.62% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$30,764.00 |
1.60% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$29,657.42 |
1.54% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$28,155.40 |
1.46% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$26,018.86 |
1.35% |
| US Dollar |
$USD |
|
8,425 |
$8,424.73 |
0.44% |
| Japanese Yen |
$JPY |
|
91,571 |
$565.99 |
0.03% |
| New Zealand Dollar |
$NZD |
|
679 |
$383.74 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|